These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26703016)

  • 1. [Detection of mutations in the gyrA and gyrB genes associated with fluoroquinolone-resistance among clinical isolates of Mycobacterium abscessus in China].
    Chen S; Nie W; Shang Y; Liang Q; Fu Y; Ma Y; Chu N; Huang H
    Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jul; 38(7):507-10. PubMed ID: 26703016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
    Nosova EY; Bukatina AA; Isaeva YD; Makarova MV; Galkina KY; Moroz AM
    J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efflux pump effects on levofloxacin resistance in
    Teng T; Chen S; Huo F; Jia J; Zhao L; Jiang G; Wang F; Chu N; Huang H
    Antimicrob Agents Chemother; 2024 May; 68(5):e0134823. PubMed ID: 38572960
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in
    Zhang X; Chen X; Wang B; Fu L; Huo F; Gao T; Pang Y; Lu Y; Li Q
    Microb Drug Resist; 2022 Mar; 28(3):280-287. PubMed ID: 34981969
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis.
    Qiao M; Ren W; Guo H; Huo F; Shang Y; Wang Y; Gao M; Pang Y
    Int J Infect Dis; 2021 May; 106():295-299. PubMed ID: 33864922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene.
    Huo F; Zhang F; Xue Y; Shang Y; Liang Q; Ma Y; Li Y; Zhao L; Pang Y
    Int J Infect Dis; 2020 Mar; 92():241-246. PubMed ID: 31978580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
    Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in
    Kim SY; Jhun BW; Moon SM; Shin SH; Jeon K; Kwon OJ; Yoo IY; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Suh GY; Koh WJ
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates.
    Teng C; Li L; Su D; Li H; Zhao B; Xia H; Teng H; Song Y; Zheng Y; Cao X; Zheng H; Zhao Y; Ou X
    Heliyon; 2024 Jun; 10(11):e31959. PubMed ID: 38868072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
    Thapa J; Chizimu JY; Kitamura S; Akapelwa ML; Suwanthada P; Miura N; Toyting J; Nishimura T; Hasegawa N; Nishiuchi Y; Gordon SV; Nakajima C; Suzuki Y
    Microbiol Spectr; 2023 Jun; 11(3):e0508822. PubMed ID: 37067420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
    Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
    J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.
    Spigaglia P; Barbanti F; Louie T; Barbut F; Mastrantonio P
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2463-8. PubMed ID: 19364867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.
    Yu X; Wang G; Chen S; Wei G; Shang Y; Dong L; Schön T; Moradigaravand D; Parkhill J; Peacock SJ; Köser CU; Huang H
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5232-7. PubMed ID: 27324769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
    Malik S; Willby M; Sikes D; Tsodikov OV; Posey JE
    PLoS One; 2012; 7(6):e39754. PubMed ID: 22761889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic detection of fluoroquinolone resistance in drug-resistant Mycobacterium tuberculosis at a tertiary care centre in south Coastal Karnataka, India.
    Chawla K; Kumar A; Shenoy VP; Chakrabarty S; Satyamoorthy K
    J Glob Antimicrob Resist; 2018 Jun; 13():250-253. PubMed ID: 29421317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Chien JY; Chiu WY; Chien ST; Chiang CJ; Yu CJ; Hsueh PR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
    Avalos E; Catanzaro D; Catanzaro A; Ganiats T; Brodine S; Alcaraz J; Rodwell T
    PLoS One; 2015; 10(3):e0120470. PubMed ID: 25816236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subspecies distribution and macrolide and fluoroquinolone resistance genetics of Mycobacterium abscessus in Korea.
    Kim J; Sung H; Park JS; Choi SH; Shim TS; Kim MN
    Int J Tuberc Lung Dis; 2016 Jan; 20(1):109-14. PubMed ID: 26688536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific gyrA Gene Mutations Correlate with High Prevalence of Discordant Levofloxacin Resistance in Mycobacterium tuberculosis Isolates from Beijing, China.
    Huo F; Ma Y; Li S; Xue Y; Shang Y; Dong L; Li Y; Pang Y
    J Mol Diagn; 2020 Sep; 22(9):1199-1204. PubMed ID: 32619641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.